ADMA Biologics’ ADMA shares have lost 8.9% in a month against the industry’s growth of 6.6%. The company has put up a ...
Rising Incidence of Hemophilia, Immunological Disorders, and the Growing Number of Surgical Procedures Worldwide is Driving Growth, at a CAGR of ~9%< ...